Clinical Trial Update: A Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating IMM-101 in combination with radiation-induced tumour necrosis for colorectal cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• IMM 101

Snippet

Sponsor: Immodulon Therapeutics Ltd | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-11-25